Murray Suzanne, Mohty Mohamad, Peloquin Sophie, Van de Donk Niels W, Leitão Sara, Labbé Sara, West Sharon, Hofstädter-Thalmann Eva, Sonneveld Pieter
AXDEV Group Inc., Brossard, QC, Canada.
Hematology and Cellular Therapy Department, Hospital St Antoine, University Pierre & Marie Curie, Paris, France.
Hemasphere. 2018 Mar 1;2(2):e33. doi: 10.1097/HS9.0000000000000033. eCollection 2018 Mar-Apr.
This needs-assessment aimed to identify clinical challenges faced by hematologists and hematology nurses in the diagnosis, treatment, and management of multiple myeloma, as well as contextual barriers hindering optimal care of patients with multiple myeloma. This manuscript focuses on key findings in relation to decision-making regarding new treatment options. A mixed methods study consisting of qualitative (from semistructured interviews) and quantitative data (from an online survey) was conducted in 8 European countries among hematologists and hematology nurses. The triangulated data led to the identification of 3 key findings related to decision-making: (1) Educational needs regarding mechanisms of action and side effect profiles of new therapies, (2) educational needs regarding the sequencing and combination of new agents with current therapies, and (3) contextual barriers to the integration of new agents. Specific knowledge and skill gaps were identified as causalities of the educational needs, providing information to guide future educational programs. Of note, 34% of hematologists and 69% of nurses reported suboptimal knowledge of the mechanisms of action of new agents and 30% of hematologists reported suboptimal skills integrating new agents in combination with current treatments. This needs-assessment highlighted the importance to address the educational needs and their underlying causes through medical education activities to ensure hematologists and hematology nurses are up-to-date with the latest treatments in the field as they become available. The contextual barriers identified should be considered when designing the educational programs to ensure content is applicable to the clinical reality of learners.
本次需求评估旨在确定血液科医生和血液科护士在多发性骨髓瘤的诊断、治疗及管理过程中面临的临床挑战,以及阻碍为多发性骨髓瘤患者提供最佳护理的环境障碍。本手稿聚焦于有关新治疗方案决策的关键发现。在8个欧洲国家对血液科医生和血液科护士开展了一项混合方法研究,包括定性数据(来自半结构化访谈)和定量数据(来自在线调查)。经三角互证的数据得出了与决策相关的3项关键发现:(1)对新疗法作用机制和副作用特征的教育需求;(2)对新药物与现有疗法序贯及联合使用的教育需求;(3)新药物整合的环境障碍。特定的知识和技能差距被确定为教育需求的成因,为指导未来的教育项目提供了信息。值得注意的是,34%的血液科医生和69%的护士报告称对新药物作用机制的了解欠佳,30%的血液科医生报告称在将新药物与现有治疗联合使用方面技能欠佳。本次需求评估强调了通过医学教育活动满足教育需求及其根本原因的重要性,以确保血液科医生和血液科护士在该领域有最新可用治疗方法时能及时了解。在设计教育项目时应考虑所确定的环境障碍,以确保内容适用于学习者的临床实际情况。